Retinal Biologics MarketThe Retinal Biologics Market generated USD 19.96 billion in revenue in 2021 and is projected to grow ...
When even the most highly trained surgeons perform procedures on the retina—one of the smallest, most delicate parts of the ...
Retinal gene therapy advancements may rewrite the book on treatments for age-related macular degeneration and diabetic eye diseases.
The following is a summary of “Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, ...
EP: 6.Patient Experiences, Key Clinical Trial Outcomes of the Port Delivery System ...
Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...
The first gene therapy approved by the U.S. Food and Drug Administration for an inherited retinal disease, for example, requires an injection into the space between the retina and another layer of ...
D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...
Innovative robotic surgery equipment from the University of Utah enhances retinal surgery precision, addressing challenges of ...
A robotic device developed by University of Utah engineers allows eye surgeons to perform high-precision procedures on the retina, the fragile lining on the back of the eye that is less than a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ...